Novel EXO-T vaccine using polyclonal CD4+ T cells armed with HER2-specific exosomes for HER2-positive breast cancer

Li R, Chibbar R, Xiang J

OncoTargets and Therapy 2018, 11:7089-7093

Published Date: 17 October 2018